Literature DB >> 16279273

Nonparametric prediction of event times in randomized clinical trials.

Gui-shuang Ying1, Daniel F Heitjan, Tai-Tsang Chen.   

Abstract

In clinical trials with planned interim analysis, it can be valuable for logistical reasons to predict the times of landmark events such as the 50th and 100th event. Bagiella and Heitjan (Stat Med 2001; 20: 2055-63) proposed a parametric prediction model for failure-time outcomes assuming exponential survival and Poisson enrollment. When little is known about the distributions of interest, there is concern that parametric prediction methods may be biased and inefficient if their underlying distributional assumptions are invalid. We propose nonparametric approaches to make point and interval predictions for landmark dates during the course of the trial. We obtain point predictions using the Kaplan-Meier estimator to extrapolate the survival probability into the future, selecting the time when the expected number of events is equal to the landmark number. To construct prediction intervals, we use a simulation strategy based on the Bayesian bootstrap. Monte Carlo results demonstrate the superiority of the nonparametric method when the assumptions underlying the parametric model are incorrect. We demonstrate the methods using data from a trial of immunotherapy of chronic granulomatous disease.

Entities:  

Mesh:

Year:  2004        PMID: 16279273     DOI: 10.1191/1740774504cn030oa

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  5 in total

1.  Bayesian modeling and prediction of accrual in multi-regional clinical trials.

Authors:  Yi Deng; Xiaoxi Zhang; Qi Long
Journal:  Stat Methods Med Res       Date:  2014-11-03       Impact factor: 3.021

2.  Milestone prediction for time-to-event endpoint monitoring in clinical trials.

Authors:  Fang-Shu Ou; Martin Heller; Qian Shi
Journal:  Pharm Stat       Date:  2019-02-26       Impact factor: 1.894

3.  Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting analysis dates for the IDEA collaboration.

Authors:  Lindsay A Renfro; Axel M Grothey; James Paul; Irene Floriani; Franck Bonnetain; Donna Niedzwiecki; Takeharu Yamanaka; Ioannis Souglakos; Greg Yothers; Daniel J Sargent
Journal:  Forum Clin Oncol       Date:  2014-12-10

4.  Cure modeling in real-time prediction: How much does it help?

Authors:  Gui-Shuang Ying; Qiang Zhang; Yu Lan; Yimei Li; Daniel F Heitjan
Journal:  Contemp Clin Trials       Date:  2017-05-22       Impact factor: 2.226

5.  Predicting analysis times in randomized clinical trials with cancer immunotherapy.

Authors:  Tai-Tsang Chen
Journal:  BMC Med Res Methodol       Date:  2016-02-01       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.